Robert J. Mauthe

1.2k total citations
23 papers, 568 citations indexed

About

Robert J. Mauthe is a scholar working on Cancer Research, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Robert J. Mauthe has authored 23 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 8 papers in Molecular Biology and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Robert J. Mauthe's work include Carcinogens and Genotoxicity Assessment (14 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and DNA Repair Mechanisms (4 papers). Robert J. Mauthe is often cited by papers focused on Carcinogens and Genotoxicity Assessment (14 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and DNA Repair Mechanisms (4 papers). Robert J. Mauthe collaborates with scholars based in United States, United Kingdom and Switzerland. Robert J. Mauthe's co-authors include Kenneth W. Turteltaub, R. Colin Garner, William M. Baird, John S. Vogel, Karen H. Dingley, Stephanie L. Coffing, David P. Gibson, Stewart P.H.T. Freeman, Nancy H. Shen and Christopher E. Frantz and has published in prestigious journals such as International Journal of Cancer, Carcinogenesis and Cancer Letters.

In The Last Decade

Robert J. Mauthe

22 papers receiving 514 citations

Peers

Countries citing papers authored by Robert J. Mauthe

Since Specialization

Citations

This map shows the geographic impact of Robert J. Mauthe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Mauthe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Mauthe more than expected).

Fields of papers citing papers by Robert J. Mauthe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Mauthe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Mauthe. The network helps show where Robert J. Mauthe may publish in the future.

Co-authorship network of co-authors of Robert J. Mauthe

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Mauthe. A scholar is included among the top collaborators of Robert J. Mauthe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Mauthe. Robert J. Mauthe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations 2022 ·Regulatory Toxicology and Pharmacology ·David H. Ackley, (unknown), (unknown), Todd Bourcier, (unknown), Andrew L. Goodwin, Wendy Halpern, Danuta J. Herzyk, Sven Kronenberg, Robert J. Mauthe, Jacintha Shenton, Dana Shuey, Ronald L. Wange	22
2	An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B₁, tamoxifen and vinyl chloride 2014 ·Critical Reviews in Toxicology ·Lynn H. Pottenger, Larry S. Andrews, Ammie N. Bachman, Peter J. Boogaard, Jean Cadet, Michelle R. Embry, Peter B. Farmer, Matthew W. Himmelstein, Annie M. Jarabek, Elizabeth A. Martin, Robert J. Mauthe, (unknown), R. Julian Preston, Rita Schoeny, Julie A. Skare, James A. Swenberg, Gary M. Williams, Errol Zeiger, Fagen Zhang, James H. Kim	22
3	Genetic Toxicity Assessment: Employing the Best Science for Human Safety Evaluation Part VII: Why Not Start with a Single Test: A Transformational Alternative to Genotoxicity Hazard and Risk Assessment 2007 ·Toxicological Sciences ·Warren W. Ku, Jiri Aubrecht, Robert J. Mauthe, Robert H. Schiestl, Albert J. Fornace	15
4	Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report 2006 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Peter Kasper, Yoshifumi Uno, Robert J. Mauthe, Norihide Asano, George R. Douglas, Edwin J. Matthews, Martha M. Moore, Lutz Mueller, Madoka Nakajima, (unknown), (unknown)	13
5	SFTG international collaborative study on in vitro micronucleus test 2006 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Marilyn J. Aardema, Ronald D. Snyder, (unknown), (unknown), Takeshi Morita, Robert J. Mauthe, David P. Gibson, (unknown), (unknown), Véronique Thybaud, Giocondo Lorenzon, Daniel Marzin, Elisabeth Lorge	74
6	The Syrian Hamster Embryo (SHE) Cell Transformation Assay: Review of the Methods and Results 2001 ·Toxicologic Pathology ·Robert J. Mauthe, David P. Gibson, Roderick T. Bunch, Laura Custer	32
7	Quantitation of benzo[a]pyrene-DNA adducts by postlabeling with 14C-acetic anhydride and accelerator mass spectrometry 2000 ·Chemico-Biological Interactions ·Radoslav Goldman, Billy W. Day, (unknown), Robert J. Mauthe, Kenneth W. Turteltaub, Peter G. Shields	22
8	Comparison of DNA‐adduct and tissue‐available dose levels of MeIQx in human and rodent colon following administration of a very low dose 1999 ·International Journal of Cancer ·Robert J. Mauthe, Karen H. Dingley, (unknown), Stewart P.H.T. Freeman, Robert J. Turesky, R. Colin Garner, Kenneth W. Turteltaub	3
9	Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose 1999 ·International Journal of Cancer ·Robert J. Mauthe, Karen H. Dingley, (unknown), Stewart P.H.T. Freeman, Robert J. Turesky, R. Colin Garner, Kenneth W. Turteltaub	42
10	Comparative biotransformation studies of MeIQx and PhIP in animal models and humans 1999 ·Cancer Letters ·R. Colin Garner, J. Timothy Lightfoot, (unknown), D. A. Russell, Jonathan Coxhead, W. Kutschera, Alfred Priller, William N. Rom, Peter Steier, D.J. Alexander, S. H. Leveson, Karen H. Dingley, Robert J. Mauthe, Kenneth W. Turteltaub	36
11	Quantitative imaging microscopy for the sensitive detection of administered metal containing drugs in single cells and tissue slices—a demonstration using platinum based chemotherapeutic agents 1998 ·Journal of Pharmaceutical and Biomedical Analysis ·Robert J. Mauthe, E. Sideras‐Haddad, Kenneth W. Turteltaub, Graham Bench	9
12	Distribution and metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) in female rats and their pups at dietary doses 1998 ·Carcinogenesis ·Robert J. Mauthe	25
13	Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry 1997 ·Chemico-Biological Interactions ·Ian N.H. White, Elizabeth A. Martin, Robert J. Mauthe, John S. Vogel, Kenneth W. Turteltaub, Lewis L. Smith	24
14	MeIQx-DNA adduct formation in rodent and human tissues at low doses 1997 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Kenneth W. Turteltaub, Robert J. Mauthe, Karen H. Dingley, John S. Vogel, Christopher E. Frantz, R. Colin Garner, Nancy H. Shen	61
15	Pyrethroid Decrease in Central Nervous System from Nerve Agent Pretreatment 1997 ·Journal of Applied Toxicology ·Bruce A. Buchholz, Norma H. Pawley, John S. Vogel, Robert J. Mauthe	18
16	A preliminary evaluation of accelerator mass spectrometry in the biomedical field 1997 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), R. Colin Garner, Robert J. Mauthe, Stewart P.H.T. Freeman, Kenneth W. Turteltaub	28
17	Measurement of 63Ni and 59Ni by accelerator mass spectrometry using characteristic projectile X-rays 1997 ·Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms ·J.E. McAninch, L.J. Hainsworth, Alfredo Marchetti, (unknown), Patrik R. Jones, A. Dunlop, Robert J. Mauthe, John S. Vogel, I.D. Proctor, T. Straume	28
18	Improved high-performance liquid chromatography analysis of 32P-postlabeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adducts using in-line precolumn purification 1996 ·Journal of Chromatography B Biomedical Sciences and Applications ·Robert J. Mauthe, (unknown), Kenneth W. Turteltaub	7
19	Exposure of mammalian cell cultures to benzo[a] and light results in oxidative DNA damage as measured by 8-hydroxydeoxyguanosine formation 1995 ·Carcinogenesis ·Robert J. Mauthe, (unknown), Stephanie L. Coffing, William M. Baird	68
20	Instability of (±)-7β, 8α-dihydroxy-9β, 10β-epoxy-7, 8, 9, 10-tetrahydrobenzo[a]pyrene (syn-BaPDE)- DNA adducts formed in benzo[a]pyrene-treated Wistar rat embryo cell cultures 1988 ·Carcinogenesis ·Donna Pruess-Schwartz, Robert J. Mauthe, William M. Baird	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact